Aquestive Therapeutics, Inc. Common Stock (AQST) is a publicly traded Healthcare sector company. As of May 21, 2026, AQST trades at $4.15 with a market cap of $518.74M and a P/E ratio of -6.70. AQST moved +2.20% today. Year to date, AQST is -33.07%; over the trailing twelve months it is +74.48%. Its 52-week range spans $2.12 to $7.55. Analyst consensus is strong buy with an average price target of $8.75. Rallies surfaces AQST's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for AQST combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $4.15 |
| Market Cap | $518.74M |
| P/E Ratio | -6.70 |
| EPS | $-0.62 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.55 |
| 52-Week Low | $2.12 |
| Volume | 289 |
| Avg Volume | 0 |
| Revenue (TTM) | $50.27M |
| Net Income | $-68.91M |
| Gross Margin | 63.45% |
8 analysts cover AQST: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.75.